York Capital Management Global Advisors’s Immunomedics Inc IMMU Stock Holding History

York Capital Management Global Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-302,477	Closed	-$25.7M	–	84
2020 Q3	$25.7M	Buy	+302,477	New	+$15.3M	1.43%	23

York Capital Management Global Advisors's IMMU Position: Q4 2020 in Review

York Capital Management Global Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 302,477 shares — an estimated $25.7M sold.

York Capital Management Global Advisors first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $25.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

York Capital Management Global Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
York Capital Management Global Advisors sold 302,477 Immunomedics Inc shares in Q4 2020, an estimated $25.7M.
York Capital Management Global Advisors first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
York Capital Management Global Advisors's Immunomedics Inc position peaked at $25.7M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on York Capital Management Global Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.